Financings
CHARBONE Increases $10M Convertible Loan First Drawdown Amount to $3M
Charbone Secures Additional Liquidity, Expands Oxygen Portfolio Amid Hydrogen Production Ramp-Up
Executive Summary
- Financing Update (April 23, 2026): Charbone increased the first drawdown of its secured convertible loan facility with Riverfort Global Opportunities PCC Ltd from $2.15 million to $3 million. The total facility remains up to $10 million.
- Loan Terms: Interest is 12% per annum payable in cash every 4 months. Conversion price for the first drawdown is $0.15 per unit (share + warrant). Warrants are exercisable at $0.195 for 48 months. Repayment schedule requires 10% after 6 months, 20% after 12 months, and 70% at maturity (18 months) if not converted.
- Security: The loan is secured by a first-ranking hypothec over all present and future movable property of Charbone Hydrogène Québec Inc. (Sorel-Tracy project).
- Debt Conversion: Confirmed full conversion of September 2025 Convertible Replacement Debentures totaling $2.05 million.
- Supply Agreement (April 23, 2026): Signed a three-year supply contract for Ultra High Purity (UHP) oxygen with a US-based industrial client in the "Tech Valley" region of New York.
- Strategic Context: The oxygen deal validates the company's "multi-molecule strategy," expanding beyond hydrogen into oxygen, helium, and specialty gases to serve semiconductors, AI/data centers, and pharmaceuticals.
Material Impact
- Financing Execution: The increase in the first drawdown ($2.15M to $3M) is a positive deviation from the March 31 term sheet but remains within the anticipated scope of the $10 million facility. It provides immediate liquidity for operations and Sorel-Tracy expansion but introduces significant cash interest obligations (12% annual).
- Debt Service Risk: The requirement to pay 12% interest in cash every four months creates a recurring cash burn risk for a company with early-stage revenue generation from hydrogen deliveries.
- Dilution Potential: Conversion terms ($0.15/unit) are slightly above the current market price ($0.14), suggesting potential equity dilution if the stock does not appreciate before maturity or conversion triggers. Warrants add further upside risk to share count.
- Commercial Validation: The UHP oxygen contract is a strategic milestone but lacks disclosed financial terms (volume/value). It confirms operational capability in the US market but may not materially impact near-term revenue compared to hydrogen sales.
- Overall Impact: The news reinforces capital stability and commercial progress without altering the fundamental risk profile of high dilution and debt service.
CH · Price
Company Overview
- Core Business: Charbone produces Ultra High Purity (UHP) hydrogen and other industrial gases (oxygen, helium).
- Flagship Project: Sorel-Tracy facility in Quebec. Phase 1A was completed and commercially launched in December 2025. Phase 1B aims to increase capacity by 4.5x to ~1 tonne per day.
- Operational Model: Modular, decentralized production with a "hub-and-spoke" distribution network across North America (Ontario, Quebec, New York) and planned expansion into Malaysia and Germany.
- Commercial Status: Active deliveries in Ontario (hydrogen/helium) and New York (hydrogen/oxygen). First helium delivery completed October 2025.
More from Charbone Hydrogen Corporation
Jun 16, 2026 · 07:25